Facebook Twitter LinkedIn Google Plus RSS

Svelte Medical raises additional $22M in private financing

By ,

New Providence-based Svelte Medical Systems announced today it has raised $22 million in private financing.

According to the announcement, in addition to participation by current investors, the round was lead by CNF Investments and New Science Ventures, bringing a total of approximately $65 million invested into the company since its inception in 2007. Proceeds from this round of financing will be used to complete the DIRECT II study, prepare for commercialization of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) and Rapid-Exchange (RX) platforms in Europe and expand overall operational infrastructure.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy